133 related articles for article (PubMed ID: 24389337)
1. Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy.
Luo C; Sun J; Du Y; He Z
J Control Release; 2014 Feb; 176():94-103. PubMed ID: 24389337
[TBL] [Abstract][Full Text] [Related]
2. Recent advances of cocktail chemotherapy by combination drug delivery systems.
Hu Q; Sun W; Wang C; Gu Z
Adv Drug Deliv Rev; 2016 Mar; 98():19-34. PubMed ID: 26546751
[TBL] [Abstract][Full Text] [Related]
3. Emerging Voices in Drug Delivery - Harnessing and Modulating Complex Biological Systems (Issue 2).
Owen SC; Nguyen J
Adv Drug Deliv Rev; 2024 May; 208():115293. PubMed ID: 38521245
[No Abstract] [Full Text] [Related]
4. Emerging Trends and Translational Challenges in Drug and Vaccine Delivery.
Kumar P; Agrahari V
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258108
[TBL] [Abstract][Full Text] [Related]
5. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
6. Improved oral absorption of doxorubicin by amphiphilic copolymer of lysine-linked ditocopherol polyethylene glycol 2000 succinate: in vitro characterization and in vivo evaluation.
Wang J; Li L; Du Y; Sun J; Han X; Luo C; Ai X; Zhang Q; Wang Y; Fu Q; Yang Z; He Z
Mol Pharm; 2015 Feb; 12(2):463-73. PubMed ID: 25581352
[TBL] [Abstract][Full Text] [Related]
7. Star-shape redox-responsive PEG-sheddable copolymer of disulfide-linked polyethylene glycol-lysine-di-tocopherol succinate for tumor-triggering intracellular doxorubicin rapid release: head-to-head comparison.
Ai X; Sun J; Zhong L; Wu C; Niu H; Xu T; Lian H; Han X; Ren G; Ding W; Wang J; Pu X; He Z
Macromol Biosci; 2014 Oct; 14(10):1415-28. PubMed ID: 24948160
[TBL] [Abstract][Full Text] [Related]
8. PEG-stabilized bilayer nanodisks as carriers for doxorubicin delivery.
Zhang W; Sun J; Liu Y; Tao M; Ai X; Su X; Cai C; Tang Y; Feng Z; Yan X; Chen G; He Z
Mol Pharm; 2014 Oct; 11(10):3279-90. PubMed ID: 24754897
[TBL] [Abstract][Full Text] [Related]
9. PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases.
Guo X; Zuo X; Zhou Z; Gu Y; Zheng H; Wang X; Wang G; Xu C; Wang F
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901762
[TBL] [Abstract][Full Text] [Related]
10. Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics.
Ünal S; Doğan O; Aktaş Y
Beilstein J Nanotechnol; 2022; 13():1393-1407. PubMed ID: 36483636
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine and versatile therapies for cancer treatment.
Shukla A; Maiti P
MedComm (2020); 2022 Sep; 3(3):e163. PubMed ID: 35992969
[TBL] [Abstract][Full Text] [Related]
12.
Zhao H; Han B; Li X; Sun C; Zhai Y; Li M; Jiang M; Zhang W; Liang Y; Kai G
Front Pharmacol; 2022; 13():872085. PubMed ID: 35600860
[TBL] [Abstract][Full Text] [Related]
13. Potential enhancement of metformin hydrochloride in solidified reverse micellar solution-based PEGylated lipid nanoparticles targeting therapeutic efficacy in diabetes treatment.
Kenechukwu FC; Nnamani DO; Duhu JC; Nmesirionye BU; Momoh MA; Akpa PA; Attama AA
Heliyon; 2022 Mar; 8(3):e09099. PubMed ID: 35309393
[TBL] [Abstract][Full Text] [Related]
14. Exosomal cargoes in OSCC: current findings and potential functions.
Zhao C; Zhang G; Liu J; Zhang C; Yao Y; Liao W
PeerJ; 2020; 8():e10062. PubMed ID: 33194377
[TBL] [Abstract][Full Text] [Related]
15. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
[TBL] [Abstract][Full Text] [Related]
16. Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel.
Ding D; Sun B; Cui W; Chen Q; Zhang X; Zhang H; He Z; Sun J; Luo C
Asian J Pharm Sci; 2019 Sep; 14(5):552-558. PubMed ID: 32104482
[TBL] [Abstract][Full Text] [Related]
17. Polymeric nanoparticles developed by vitamin E-modified aliphatic polycarbonate polymer to promote oral absorption of oleanolic acid.
Zhang W; Liang C; Liu H; Li Z; Chen R; Zhou M; Li D; Ye Q; Luo C; Sun J
Asian J Pharm Sci; 2017 Nov; 12(6):586-593. PubMed ID: 32104372
[TBL] [Abstract][Full Text] [Related]
18. The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration
Li Z; Tao W; Zhang D; Wu C; Song B; Wang S; Wang T; Hu M; Liu X; Wang Y; Sun Y; Sun J
Asian J Pharm Sci; 2017 May; 12(3):285-291. PubMed ID: 32104340
[TBL] [Abstract][Full Text] [Related]
19. Hybrid curcumin-phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancer.
Liu Y; Huang P; Hou X; Yan F; Jiang Z; Shi J; Xie X; Shen J; Fan Q; Wang Z; Feng N
Int J Nanomedicine; 2019; 14():3311-3330. PubMed ID: 31190795
[No Abstract] [Full Text] [Related]
20. Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy.
Cui W; Zhao H; Wang C; Chen Y; Luo C; Zhang S; Sun B; He Z
Drug Deliv; 2019 Dec; 26(1):542-550. PubMed ID: 31090467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
